Latest News in the pharma Industry

Market News

Ipsen to acquire oncology assets from Merrimack Pharmaceuticals

Ipsen to acquire oncology assets from Merrimack Pharmaceuticals

16 Jan 2017

Transaction includes US commercialization rights for Onivyde for metastatic pancreatic cancer in adult patients.

Read more 
Tesaro receives CRL for rolapitant IV from FDA

Tesaro receives CRL for rolapitant IV from FDA

15 Jan 2017

No concerns raised by FDA related to the rolapitant IV efficacy or safety profile and additional clinical studies are not required.

Read more 
New-generation mealtime insulin approved in Europe

New-generation mealtime insulin approved in Europe

14 Jan 2017

Novo Nordisk to launch Fiasp in first half of 2017.

Read more 
VivaGel BV granted QIDP and Fast Track designation by FDA

VivaGel BV granted QIDP and Fast Track designation by FDA

14 Jan 2017

Product receives designations for both the BV treatment and prevention indications.

Read more 
Sartorius Stedim Biotech opens a new validation service laboratory at its Shanghai site

Sartorius Stedim Biotech opens a new validation service laboratory at its Shanghai site

12 Jan 2017

Comprehensive validation services for the Chinese market.

Read more 
Merck Licenses four oncology R&D programs from Vertex

Merck Licenses four oncology R&D programs from Vertex

12 Jan 2017

All programs (two promising clinical-stage programs targeting DNA damage and repair, and two novel pre-clinical programs) have first-in-class and best-in-class potential.

Read more 
US Court of Appeals rules in Lilly's favour on Alimta vitamin regimen patent

US Court of Appeals rules in Lilly's favour on Alimta vitamin regimen patent

12 Jan 2017

If the patent is ultimately upheld through all remaining challenges, Alimta would maintain US exclusivity until May 2022.

Read more 
Lilly and Merck expand immuno-oncology collaboration

Lilly and Merck expand immuno-oncology collaboration

11 Jan 2017

New study to evaluate combination of Lartruvo and Keytruda.

Read more 
Stellar Biotechnologies advances strategic plan to secure key production region

Stellar Biotechnologies advances strategic plan to secure key production region

11 Jan 2017

Company aims to increase production capacity to supply multiple commercial-scale therapeutic vaccines under development.

Read more 
Piqur and Pierre Fabre announce partnership in dermato-oncology

Piqur and Pierre Fabre announce partnership in dermato-oncology

11 Jan 2017

Collaboration will give Pierre Fabre the option to enter into exclusive negotiations to license global rights for the program in selected skin cancer conditions.

Read more 
Merck expands end-to-end biodevelopment centers

Merck expands end-to-end biodevelopment centers

10 Jan 2017

Expansionincludes the opening of two new process development centers in the US and China.

Read more 
Pharma predictions for 2017: the good, the bad, and the Donald

Pharma predictions for 2017: the good, the bad, and the Donald

10 Jan 2017

Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities.

Read more